Dr Charlotte Pawlyn's group focusses on identifying and validating therapeutic targets for the treatment of immunomodulatory drug resistant and high-risk multiple myeloma, a bone marrow cancer.
Dr Charlotte Pawlyn is the group leader of the Myeloma Biology and Therapeutics Group and Career Development Faculty at the Institute of Cancer Research and an Honorary Consultant in Haematology at The Royal Marsden NHS Foundation Trust.